Organogenesis Holdings (ORGO) EBT (2016 - 2026)

Organogenesis Holdings' EBT history runs 11 years deep, the most recent figure standing at -$68.5 million for Q1 2026.

• In Q1 2026, EBT fell 165.57% year-over-year to -$68.5 million; the TTM figure through Mar 2026 stood at $4.3 million (up 117.65% YoY), while the FY2025 annual figure was $47.0 million, up 1773.32% from the prior year.
• EBT was -$68.5 million for Q1 2026 at Organogenesis Holdings, down from $63.4 million in the prior quarter.
• In the past five years, EBT ranged from a high of $63.4 million in Q4 2025 to a low of -$68.5 million in Q1 2026.
• Historically, EBT has averaged $374411.8 across 5 years, with a median of $1.2 million in 2022.
• The sharpest annual moves came in 2024 and 2025: EBT soared 670.88% in 2024, then plunged 493.67% in 2025.
• A 5-year view of EBT shows it stood at $8.8 million in 2022, then sank by 120.52% to -$1.8 million in 2023, then jumped by 670.88% to $10.3 million in 2024, then soared by 518.62% to $63.4 million in 2025, then tumbled by 207.96% to -$68.5 million in 2026.
• The last three EBT figures came in at -$68.5 million (Q1 2026), $63.4 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.